Effect of gut bacteria on specific immune cells underlies persistent liver inflammation

January 16, 2018, Agency for Science, Technology and Research (A*STAR), Singapore

Persistent liver inflammation in sufferers of chronic viral hepatitis is likely caused by interactions between pro-inflammatory immune cells in the liver and products from gut bacteria, according to new work involving A*STAR researchers. The findings identify new therapeutic targets.

Chronic viral hepatitis is characterized by of the liver, but the mechanism that maintains this has been poorly understood. The degree of inflammation does not correspond to the extent of viral activity in the liver, or to the activity of that specifically target the virus, as might be expected.

The new work, a collaboration between the laboratories of Antonio Bertoletti at the Duke-NUS Medical and Singapore Institute of Clinical Sciences, the laboratory of Qingfeng Chen at the A*STAR Institute of Molecular and Cell Biology and Charles-Antoine Dutertre in the laboratory of Florent Ginhoux from the A*STAR Singapore Immunology Network, aimed to determine the mechanisms underpinning the inflammation. The researchers focused on a different group of immune cells called , which are increasingly recognized as significant in .

They analyzed the molecular and functional profiles of macrophages in the livers of patients with chronic viral hepatitis and those of healthy people. In the livers of patients, there was an excess of macrophages with a specific profile that promotes inflammation. "Unlike macrophages found in a healthy liver, these macrophages have the capacity to continuously produce pro-inflammatory mediators when they encounter bacterial products," explains Dutertre.

The team studied this phenomenon further in mice engineered to have human liver cells and . The mice were infected with hepatitis B virus, and consequently accumulated the same pro-inflammatory macrophage population in the liver as that seen in patients. Treatment of the mice with antibiotics to reduce the reversed the accumulation of these macrophages. "This demonstrated that bacterial products that leak from the gut into the liver are responsible for the accumulation of the pro-inflammatory macrophages," says Dutertre.

The results identify a novel mechanism that maintains inflammation in chronic viral hepatitis. Dutertre and colleagues say that their findings suggest new therapeutic approaches, in addition to targeting the virus, that involve modifying the intestinal bacteria or depleting the pro-inflammatory macrophages in the liver.

The researchers are now investigating the mechanism behind the effects of bacterial products on macrophages in the liver. So far they have identified certain soluble mediators that play a pivotal role. "Our hypothesis is that by inhibiting these soluble mediators, we could limit the accumulation of the pro-inflammatory macrophages and resolve inflammation in patients with chronic viral hepatitis," concludes Dutertre.

Explore further: Zinc may hold key to fighting liver disease

More information: Alfonso Tan-Garcia et al. Intrahepatic CD206 + macrophages contribute to inflammation in advanced viral-related liver disease, Journal of Hepatology (2017). DOI: 10.1016/j.jhep.2017.04.023

Related Stories

Zinc may hold key to fighting liver disease

June 1, 2017
New research from the Westmead Institute's Storr Liver Centre in collaboration with the Centre for Virus Research and Kirby Institute has shown that serum zinc may benefit liver disease in a way we never expected.

Role of transcriptional co-factor hints at possible inflammatory bowel disease treatment

December 12, 2017
Inflammatory bowel disease (IBD), including the two conditions ulcerative colitis and Crohn's disease, results in long-term inflammation of the gut and is associated with dysregulation of the immune system. However, it is ...

A new mechanism protecting the liver from dangerous inflammation

May 28, 2015
Life-threatening liver inflammation can be caused by excess alcohol, fatty foods, toxins, as well as viral, bacterial, and parasite infections. A study published on May 28th in PLOS Pathogens reports that a specific immune ...

New test can predict death in patients with serious liver disease

April 1, 2016
Acute-on-chronic liver failure (ACLF) is a sudden deterioration of the liver function in a patient with liver cirrhosis accompanied by failure of one or more organ systems. This liver disease has a serious prognosis and the ...

Study finds molecules present possible biomarkers of HCV-related liver damage progression

October 25, 2017
Hepatitis C virus infection leads to a wide spectrum of liver diseases ranging from mild chronic hepatitis to end-stage cirrhosis and hepatocellular carcinoma. An intriguing aspect of the HCV infection is its close connection ...

Inflammatory signature of nonalcoholic fatty liver disease

May 16, 2017
A team of investigators led by Rohit Kohli, MBBS, MS, of Children's Hospital Los Angeles, has identified key inflammatory cells involved in nonalcoholic fatty liver disease. Current treatment for the disorder involves changes ...

Recommended for you

New cytokine network can repair tissue damage in the intestine, study finds

May 16, 2018
A new group of proteins called cytokines, critical for antimicrobial activity and repairing the damaged intestinal tissue found in inflammatory bowel disease (IBD), has been discovered by researchers in a study led by Georgia ...

International study suggests alternative treatment for mild asthma

May 16, 2018
A large international study led by a Hamilton researcher has found a patient-centric treatment that works for people with mild asthma.

Study shows yogurt may dampen chronic inflammation linked to multiple diseases

May 14, 2018
Inflammation can be good. It's part of the body's innate immune system, our first line of defense against illness and injury.

New study provides insight into blood signatures of inflammation

May 8, 2018
A new study from Boston University Schools of Medicine (BUSM) and Public Health (BUSPH) identifies a pattern of inflammation associated with cardio-metabolic risks among participants in the Black Women's Health Study, as ...

Metabolites shed by intestinal microbiota keep inflammation at bay

May 4, 2018
Researchers at Tufts University have elucidated a mechanism by which the "good" bacteria that reside in our gastrointestinal tract can help protect us from inflammation, and how their disruption (dysbiosis) can increase the ...

Bowel disease study points to new therapies for lifelong conditions

May 3, 2018
Treatments for incurable bowel conditions may be a step closer following the discovery of a key molecule associated with disease flare-ups.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.